HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Phentolamine Methanesulfonate

HCID 91430
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
65-28-1
Standard SMILES
CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
InChIKey
OGIYDFVHFQEFKQ-UHFFFAOYSA-N
Molecular formula
C18H23N3O4S
Average molar mass
377.5 g/mol
Monoisotopic mass
377.1409274

Overview

Phentolamine Mesylate is the mesylate salt of a synthetic imidazoline with alpha-adrenergic antagonist activity. As a competitive alpha-adrenergic antagonist, phentolamine binds to alpha-1 and alpha-2 receptors, resulting in a decrease in peripheral vascular resistance and vasodilatation. This agent also may block 5-hydroxytryptamine (5-HT) receptors and stimulate release of histamine from mast cells.

Names & identifiers

Preferred name
Phentolamine Methanesulfonate
IUPAC
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol;methanesulfonic acid
English name
Phentolamine mesilate
Molecular formula
C18H23N3O4S
Molecular weight
377.46

Names & synonyms

Phentolamine mesylate65-28-1phentolamine mesilatePhentolamine methanesulfonateOraVerseMesylate phentolamineRYZUMVINV-101Y7543E5K9TDTXSID60215315Mesilate, PhentolamineMesylate, Phentolamine
Show more names
REGITINVASOMAXPhentoLFE202158FE 202158amine MesyLPhentolamine meREGITIN MESYLATEregitinemesylate
RefChem:55851Methanesulfonate, PhentolamineDTXCID601378062-(N-p'-Tolyl-N-(m'-hydroxyphenyl)aminomethyl)imidazoline Monomethanesulfonate200-604-6Phentolamine (mesylate)Phentolamine methanesulfonate saltRegitine methanesulfonate

Database identifiers

CAS
65-28-1
PubChem CID
91430
DTXSID
DTXSID60215315
ChEMBL
CHEMBL1200873
UNII
Y7543E5K9T
EC Number

Properties

Computed structural properties

Topological polar surface area
111 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
6
Rotatable bonds
4
Heavy atoms
26
Formal charge
0
Complexity
456

Experimental & physicochemical properties

Solubility>56.6 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

Melting point
180 · 180-182 °C(lit.)
Density
1.2256 · 1.2256 (rough estimate)
refractive index
1.632 · 1.6320 (estimate)
storage temp.
2 · 2-8°C
solubility
26 mg/mL · ethanol: 26 mg/mL
form
powder
color
white to off-white
Water Solubility
50 mg/mL · 50 mg/mL
Merck
14 · 14,7264
Stability
Aq. Solutions Cannot be Stored
InChI
InChI=1S/C17H19N3O.CH4O3S/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15;1-5(2,3)4/h2-8,11,21H,9-10,12H2,1H3,(H,18,19);1H3,(H,2,3,4)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Other Safety InformationIMAP assessments - Phenol, 3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-, monomethanesulfonate (salt): Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Phentolamine mesylate

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
rtecs
SL5430000
ridadr
3249
hs_code
29332900
Toxicity
LDLo scu-rat: 275 mg/kg NIIRDN 6,667,82

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

PHENTOLAMINE MESYLATE

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

MeSH Pharmacological Classification · 2 items

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Applications · 2 items

UsesPhentolamine mesilate is an adrenergic blocking agent and antihypertensive. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of raynaud disease and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.

General DescriptionPhentolamine Mesylate belongs to the class of alpha adrenergic antagonist drugs. It is used in the treatment of pheochromocytoma-related hypertension, erectile dysfunction and in the diagnosis of pheochromocytoma and norepinephrine-related dermal necrosis.

Upstream & downstream products

Upstream raw materials

Methanesulfonic acidChloroacetonitrile

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
200-604-6
InChIKey
OGIYDFVHFQEFKQ-UHFFFAOYSA-N
SMILES
N(CC1=NCCN1)(C1C=CC(C)=CC=1)C1C=CC=C(O)C=1.S(=O)(=O)(O)C
FDA UNII
7543 E5K9T · Y7543E5K9T
NCI Drug Dictionary
phentolamine mesylate
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Protein binding
54 % · 54%
Excreted unchanged in urine
13 % · 13%
Biological half-life
19 minutes · 19 minutes / -
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P264-P270-P301+P312-P302+P352-P305+P351+P338
target organs
Respiratory system
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xn,Xi
Risk Statements
20 · 20/21/22-36/37/38
Safety Statements
26 · 26-36
RIDADR
3249 · 3249
WGK Germany
3 · 3
RTECS
5430000 · SL5430000
HazardClass
6.1 · 6.1(b)
PackingGroup
III
HS Code
29332900 · 29332900
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 OralEye · Acute Tox. 4 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
Toxicity
275 mg/kg · LDLo scu-rat: 275 mg/kg NIIRDN 6,667,82
risk_code
20/21/22-36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn,Xi
safety_code
26-36
hazard_class
6.1(b)
Storage Class
11 - Combustible Solids
packing_group
III
target organs
Respiratory system
Hazard statements
H302-H315-H319-H335
Hazard Classifications
Acute Tox. 4 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
Precautionary statements
P261-P264-P270-P301+P312-P302+P352-P305+P351+P338